[1] KAPLAN B, LEVENBERG S. The Role of Biomaterials in Peripheral Nerve and Spinal Cord Injury: A Review. Int J Mol Sci. 2022;23(3):1244.
[2] LOPES B, SOUSA P, ALVITES R,et al. Peripheral Nerve Injury Treatments and Advances: One Health Perspective. Int J Mol Sci. 2022;23(2):918.
[3] ZHANG M, LI L, AN H, et al. Repair of Peripheral Nerve Injury Using Hydrogels Based on Self-Assembled Peptides. Gels. 2021;7(4):152.
[4] PFISTER BJ, GORDON T, LOVERDE JR,et al. Biomedical engineering strategies for peripheral nerve repair: surgical applications, state of the art, and future challenges. Crit Rev Biomed Eng. 2011;39(2):81-124.
[5] SLAVIN BR, SARHANE KA, VON GUIONNEAU N, et al. Insulin-Like Growth Factor-1: A Promising Therapeutic Target for Peripheral Nerve Injury. Front Bioeng Biotechnol. 2021;9:695850.
[6] FERDOWSI S, ABDOLMALEKI A, ASADI A,et al. Effect of Azithromycin on Sciatic Nerve Injury in the Wistar Rats. Neurochem Res. 2023;48(1): 161-171.
[7] DIVAC N, AKSIĆ M, RASULIĆ L, et al. Pharmacology of repair after peripheral nerve injury. Int J Clin Pharmacol Ther. 2021;59(6):447-462.
[8] HUANG W, YI S, ZHAO L. Genetic Features of Young and Aged Animals After Peripheral Nerve Injury: Implications for Diminished Regeneration Capacity. Cell Mol Neurobiol. 2023;43(8):4363-4375.
[9] SIDHU G, SAPRA A. Pravastatin. 2023 Jun 21. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024.
[10] SOLHEIM S, SELJEFLOT I, ARNESEN H, et al. Reduced levels of TNF alpha in hypercholesterolemic individuals after treatment with pravastatin for 8 weeks. Atherosclerosis. 2001;157(2):411-415.
[11] SOMMEIJER DW, MACGILLAVRY MR, MEIJERS JC,et al. Anti-inflammatory and anticoagulant effects of pravastatin in patients with type 2 diabetes. Diabetes Care. 2004;27(2):468-473.
[12] LU P, LIU J, PANG X. Pravastatin inhibits fibrinogen- and FDP-induced inflammatory response via reducing the production of IL-6, TNF-α and iNOS in vascular smooth muscle cells. Mol Med Rep. 2015;12(4):6145-6151.
[13] SATO F, WAJIMA D, TAKESHIMA Y, et al. Neuroprotective effects of pravastatin in cerebral venous infarction in a rat model. IBRO Neurosci Rep. 2023;14:202-209.
[14] MAZARD T, RITZENTHALER T, DAILLER F. Pravastatin may improve neurological outcome following low-grade aneurysmal subarachnoid hemorrhage. J Clin Neurosci. 2022;98:11-14.
[15] BERGER C, XIA F, MAURER MH, et al. Neuroprotection by pravastatin in acute ischemic stroke in rats. Brain Res Rev. 2008;58(1):48-56.
[16] YALÇıNKAYA B, OCAK H, ÇOLAK AF, et al. Sciatic neurotmesis and periostitis ossificans progressiva due to a traumatic/unexpected glass injury: a case report. J Yeungnam Med Sci. 2024;41(1):45-47.
[17] HUSSAIN G, WANG J, RASUL A,et al. Current Status of Therapeutic Approaches against Peripheral Nerve Injuries: A Detailed Story from Injury to Recovery. Int J Biol Sci. 2020;16(1):116-134.
[18] VIJAYAVENKATARAMAN S. Nerve guide conduits for peripheral nerve injury repair: A review on design, materials and fabrication methods. Acta Biomater. 2020;106:54-69.
[19] LIU X, DUAN X. Mechanisms and Treatments of Peripheral Nerve Injury. Ann Plast Surg. 2023;91(2):313-318.
[20] ZIMMERMANN KS, AMAN M, HARHAUS L, et al. Improving outcomes in traumatic peripheral nerve injuries to the upper extremity. Eur J Orthop Surg Traumatol. 2023 Oct 21. doi: 10.1007/s00590-023-03751-3.
[21] SAFA B, JAIN S, DESAI MJ, et al. Peripheral nerve repair throughout the body with processed nerve allografts: Results from a large multicenter study. Microsurgery. 2020;40(5):527-537.
[22] PEREIRA C, LAZAR SV, WANG A. Bioengineering approaches for nerve graft revascularization: Current concepts and future directions. WIREs Mech Dis. 2023;15(4):e1609.
[23] YU T, AO Q, AO T, et al. Preparation and assessment of an optimized multichannel acellular nerve allograft for peripheral nerve regeneration. Bioeng Transl Med. 2022;8(4):e10435.
[24] LOVATI AB, D’ARRIGO D, ODELLA S,et al. Nerve Repair Using Decellularized Nerve Grafts in Rat Models. A Review of the Literature. Front Cell Neurosci. 2018;12:427.
[25] BOLANDGHAMAT S, BEHNAM-RASSOULI M. Recent Findings on the Effects of Pharmacological Agents on the Nerve Regeneration after Peripheral Nerve Injury. Curr Neuropharmacol. 2020;18(11):1154-1163.
[26] DAIMON M, AOMI S, KAWAMATA T,et al. Pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, reduces delayed neuronal death following transient forebrain ischemia in the adult rat hippocampus. Neurosci Lett. 2004;362(2):122-126.
[27] TRAMONTINA AC, WARTCHOW KM, RODRIGUES L,et al. The neuroprotective effect of two statins: simvastatin and pravastatin on a streptozotocin-induced model of Alzheimer’s disease in rats. J Neural Transm (Vienna). 2011;118(11):1641-1649.
[28] AL-SAEDI HF, PANAHI Y, GHANIMI HA,et al. Enhancement of nerve regeneration with nimodipine treatment after sciatic nerve injury. Fundam Clin Pharmacol. 2023;37(1):107-115.
[29] SHAN C, ZHANG C, ZHANG C. The Role of IL-6 in Neurodegenerative Disorders. Neurochem Res. 2024 Jan 16. doi: 10.1007/s11064-023-04085-6.
[30] KOULAXOUZIDIS G, REIM G, FLUHR JW,et al. In Situ Deactivation of Interleukin-6 Enhances Early Peripheral Nerve Regeneration in a Murine Injury Model. J Reconstr Microsurg. 2015;31(7):508-515.
[31] HUANG Z, ZHONG L, ZHU J,et al. Inhibition of IL-6/JAK/STAT3 pathway rescues denervation-induced skeletal muscle atrophy. Ann Transl Med. 2020;8(24):1681.
[32] IDRISS HT, NAISMITH JH.TNF alpha and the TNF receptor superfamily: structure-function relationship(s). MicroscResTech. 2000;50(3):184-195.
[33] URABE H, TERASHIMA T, LIN F, et al. Bone marrow-derived TNF-α causes diabetic neuropathy in mice. Diabetologia. 2015;58(2):402-410.
[34] LORENZINI L, BALDASSARRO VA, STANZANI A,et al. Nerve Growth Factor: The First Molecule of the Neurotrophin Family. Adv Exp Med Biol. 2021;1331:3-10.
[35] KOPACH O, PAVLOV AM, SINDEEVA OA, et al. Biodegradable Microcapsules Loaded with Nerve Growth Factor Enable Neurite Guidance and Synapse Formation. Pharmaceutics. 2020;13(1):25.
[36] MIZUSHIMA N, KOMATSU M. Autophagy: renovation of cells and tissues. Cell. 2011;147(4):728-741.
[37] DODSON M, WANI WY, REDMANN M, et al. Regulation of autophagy, mitochondrial dynamics, and cellular bioenergetics by 4-hydroxynonenal in primary neurons. Autophagy. 2017;13(11): 1828-1840.
[38] LI R, LI D, WU C, et al. Nerve growth factor activates autophagy in Schwann cells to enhance myelin debris clearance and to expedite nerve regeneration. Theranostics. 2020;10(4):1649-1677.
[39] FLETCHER JL, MURRAY SS, XIAO J. Brain-Derived Neurotrophic Factor in Central Nervous System Myelination: A New Mechanism to Promote Myelin Plasticity and Repair. Int J Mol Sci. 2018;19(12):4131.
[40] ARANAZ I, ACOSTA N, REVUELTA J, et al. Fast and Sustained Axonal Growth by BDNF Released from Chitosan Microspheres. Mar Drugs. 2023;21(2):91.
[41] LAN G, DU J, CHEN X,et al. Association of APOE-ε4 and GAP-43-related presynaptic loss with β-amyloid, tau, neurodegeneration, and cognitive decline. Neurobiol Aging. 2023;132:209-219.
[42] SHI LF, WANG CJ, YU KW, et al. An Enriched Environment Promotes Motor Function through Neuroprotection after Cerebral Ischemia. Biomed Res Int. 2023;2023:4143633.
[43] CHATO-ASTRAIN J, RODA O, SÁNCHEZ-PORRAS D, et al. Peripheral nerve regeneration through nerve conduits evokes differential expression of growth-associated protein-43 in the spinal cord. Neural Regen Res. 2023;18(8):1852-1856.
[44] MANKAVI F, IBRAHIM R, WANG H. Advances in Biomimetic Nerve Guidance Conduits for Peripheral Nerve Regeneration. Nanomaterials (Basel). 2023;13(18):2528.
[45] WU X, LI H, YIN J, et al. [Experimental study on the construction of telmisartan/collagen/polycaprolactone nerve conduit and its repair effect on rat sciatic nerve defect]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2022;36(3):352-361.
[46] LI Y, KAMEI Y, KAMBE M, et al. Peripheral Nerve Regeneration Using Different Germ Layer-Derived Adult Stem Cells in the Past Decade. Behav Neurol. 2021;2021:5586523. |